Gujarat Alkalies and Chemicals Limited has informed the Exchange regarding Appointment of M/s Talati & Talati LLP as Internal Auditor of the company w.e.f. July 01, 2025.
GUJALKALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited financial results for Q4 and FY25 (ended 31 March 2025). On a standalone basis, the company swung to a net profit of Rs. 9.72 crore in FY25 from a loss of Rs. 185.88 crore in FY24, while revenue rose modestly to Rs. 4,072.91 crore (vs Rs. 3,806.63 crore). Consolidated results, however, remain in the red with a net loss of Rs. 71.22 crore (vs Rs. 300.48 crore loss), dragged by the 60% GACL-NALCO joint venture which posted a loss of Rs. 134.96 crore and accumulated losses of Rs. 594.68 crore. The board recommended a final dividend of Rs. 15.80 per share (158% on face value), totalling Rs. 116.03 crore. M/s Talati & Talati LLP was appointed as Internal Auditor for one year from 1 July 2025, and M/s Samdani Shah & Kabra as Secretarial Auditor for five years. IAS officer Shri S J Haider was inducted as Additional Director, subject to shareholder approval via postal ballot.
Shareholders get a healthy Rs. 15.80/share dividend and will welcome the standalone turnaround. However, the consolidated loss, the bleeding joint venture, a new financial guarantee obligation of Rs. 32.34 crore backing JV debentures, and a post-balance-sheet technical shutdown at the JV plant are risks that could weigh on sentiment despite the clean auditor's opinion.